SCHEMBL26985702

SCHEMBL26985702

CCOOB(O)c1cccnc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
KMT2A Q03164 1/20 0.36
CHRNB2 P17787 3/20 0.36
CHRNA4 P43681 3/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
CYP19A1 P11511 2/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3515822 0.83 CHRNB2 (0.38) LMNAKMT2ACHRNB2CHRNA4CCNC
SCHEMBL568870 0.81 ALDH1A1 (0.41) LMNAKMT2ACHRNB2CHRNA4ALDH1A1
SCHEMBL28857039 0.80 KMT2A (0.46) LMNAKMT2ACHRNB2CHRNA4ALDH1A1
SCHEMBL264493 0.78 PCSK9 (0.42) KMT2AL3MBTL1TSHR
SCHEMBL2416877 0.78 ALDH1A1 (0.35) LMNAKMT2ACHRNB2CHRNA4CCNC
SCHEMBL2270306 0.77 ALDH1A1 (0.43) LMNAKMT2ACHRNB2CHRNA4ALDH1A1
SCHEMBL8131766 0.76 ALDH1A1 (0.41) LMNAKMT2ACHRNB2CHRNA4ALDH1A1
SCHEMBL13712395 0.74 F7 (0.39) LMNAKMT2ACHRNB2CHRNA4ALDH1A1
SCHEMBL4475691 0.74 SMN1; SMN2 (0.37) LMNAKMT2ACHRNB2CHRNA4L3MBTL1
SCHEMBL3984743 0.73 ACHE (0.38) LMNAALDH1A1KDM4EMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107658-A2 INHIBITORS OF TYK2 VYRNWY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed
WO-2024020517-A1 3-(6-PYRIDIN-3-YL)-2-[4-(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)PIPERIDIN-1-YL]BENZONITRILE DERIVATIVES AND SIMILAR COMPOUNDS AS QPCTL AND QPCT INHIBITORS FOR THE TREATMENT OF CANCER 858 THERAPEUTICS, INC. (US) 2024-01-25 WO disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed